분자 생물학적 기법의 신속약제감수성검사로 진단한 Rifampin 내 성에 의한 재발 결핵 2례
Rifampin-resistant Relapsed Tuberculosis Confirmed by Molecular Technique
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Recurrent tuberculosis can be caused by a relapse of the original infecting strain, a re infection with a new strain of Mycobacterium tuberculosis or a paradoxical response associated with the anti-tuberculosis treatment. A drug susceptibility test is important when evaluating recurrent tuberculosis but a conventional microbiological test may be unavailable or unsuccessful. Recently, direct molecular testing as a line probe assay (GenoType® MTBDRplus, Hain Lifescience GmbH, Nehren, Germany) has shown promising results for the diagnosis or treatment of drug-resistant tuberculosis. We present two cases of rifampin-resistant, relapsed tuberculosis that were confirmed using a molecular technique.
Abstract
Recurrent tuberculosis can be caused by a relapse of the original infecting strain, a re infection with a new strain of Mycobacterium tuberculosis or a paradoxical response associated with the anti-tuberculosis treatment. A drug susceptibility test is important when evaluating recurrent tuberculosis but a conventional microbiological test may be unavailable or unsuccessful. Recently, direct molecular testing as a line probe assay (GenoType® MTBDRplus, Hain Lifescience GmbH, Nehren, Germany) has shown promising results for the diagnosis or treatment of drug-resistant tuberculosis. We present two cases of rifampin-resistant, relapsed tuberculosis that were confirmed using a molecular technique.
참고문헌 (28)
- Jasmer RM., "Recurrent tuberculosis in the United States and Canada : relapse or reinfection?", Am J Respir Crit Care Med, 170, pp.1360~1366 (2004)
- Anonymous., "A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report : results during the 24 months after the end of chemotherapy", Am Rev Respir Dis, 126, pp.460~462 (1982)
- Anonymous., "Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for tuberculosis. Hong Kong Chest Service", British Medical Research Council, 1987, pp.136, 1339~1342
- B lumberg HM., "American Thoracic Society", Centers for Disease Control and Prevention, Am J Respir Crit Care Med, pp.2003, 167[DOI]
- Verver S., "Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis", Am J Respir Crit Care Med, 171, pp.1430~1435 (2005)
- Palaci M., "Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis", J Clin Microbiol, 45, pp.4064~4066 (2007)
- Chang KC., "A nested casecontrol study on treatment-related risk factors for early relapse of tuberculosis", Am J Respir Crit Care Med, 170, pp.1124~1130 (2004)
- Seung KJ., "The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis", Clin Infect Dis, 39, pp.1321~1328 (2004)
- Espinal MA., "Standard short-course chemotherapy for drug-resistant tuberculosis : treatment outcomes in 6 countries", JAMA, 283, pp.2537~2545 (2000)
- Joon Sung Joh, "The Interval Between Initiation of Anti-tuberculosis Treatment in Patients with Culture-positive Pulmonary Tuberculosis and Receipt of Drug-susceptibility Test Results", Journal of Korean Medical Science, 22(1), pp.26~29 (2007), 대한의학회
- Kim SJ., "Drug-susceptibility testing in tuberculosis : methods and reliability of results", Eur Respir J, 25, pp.564~569 (2005)
- Han MD., "A Study on the drug susceptibility test of multi-drug resistant tuberculosis patients", Korean J Epidemiol, 30, pp.301~308 (2008)
- Pai M., "New tools and emerging technologies for the diagnosis of tuberculosis : part II. Active tuberculosis and drug resistance", Expert Rev Mol Diagn, 6, pp.423~432 (2006)
- Bai GH., "Trend of anti-tuberculosis drug resistance in Korea, 1994-2004", Int J Tuberc Lung Dis, 11, pp.571~576 (2007)
- 윤늘봄, "일개 부산지역 3차 병원에서 관찰한 다제내성 결핵의 실태, 2005∼2009", Tuberculosis and Respiratory Diseases, 71(2), pp.120~125 (2011), 대한결핵및호흡기학회
- 조오현, "폐외결핵 환자에서의 항결핵제 내성", Infection and Chemotherapy, 43(3), pp.258~261 (2011), 대한감염학회
- Telenti A., "Detection of rifampicinresistance mutations in Mycobacterium tuberculosis", Lancet, 341, pp.647~650 (1993)
- Musser JM., "Antimicrobial agent resistance in mycobacteria : molecular genetic insights", Clin Microbiol Rev, 8, pp.496~514 (1995)
- Wade MM., "Mechanisms of drug resistance in Mycobacterium tuberculosis", Front Biosci, 9, pp.975~994 (2004)
- Morgan M., "A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis : a systematic review and meta-analysis", BMC Infect Dis, 5, pp.62~ (2005)
- Wilson ML., "Recent advances in the laboratory detection of Mycobacterium tuberculosis complex and drug resistance", Clin Infect Dis, 52, pp.1350~1355 (2011)
- Hillemann D., "Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacincapreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens", J Clin Microbiol, 47, pp.1767~1772 (2009)
- Boehme CC., "Rapid molecular detection of tuberculosis and rifampin resistance", N Engl J Med, 363, pp.1005~1015 (2010)
- Hillemann D., "Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens", J Clin Microbiol, 45, pp.2635~2640 (2007)
- Causse M., "Evaluation of new GenoType MTBDRplus for detection of resistance in cultures and direct specimens of Mycobacterium tuberculosis", Int J Tuberc Lung Dis, 12, pp.1456~1460 (2008)
- Huang WL., "Performance assessment of the GenoType MTBDRplus test and DNA sequencing in detection of multidrug-resistant Mycobacterium tuberculosis", J Clin Microbiol, 47, pp.2520~2524 (2009)
- 정태동, "객담 검체에서 다제내성 결핵균의 검출을 위한 GenoType® MTBDRplus의 평가", Laboratory Medicine Online, 1(1), pp.19~25 (2011), 대한진단검사의학회
- Hillemann D., "Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens", J Clin Microbiol, 45, pp.2635~2640 (2007)